Skip To Main Content
This platform is for Australian healthcare professionals only
Campus
Campus

Prophylaxis treatment of Haemophilia A with Eloctate (efmoroctocog alfa)

A guide on switching a Haemophilia A patient on SHL prophylaxis to Eloctate.

For more information, contact your local Haemophilia account executive

MAT-AU-2102919-2.0. Date of preparation March 2024